Retinal Degeneration Fund
North America, North Carolina, United States, Raleigh
Description
Retinal Degeneration Fund makes mission-related investments in therapeutic companies with projects nearing clinical testing.
Investor Profile
Retinal Degeneration Fund has backed more than 12 startups, with 2 new investments in the last 12 months alone. The firm has led 4 rounds, about 33% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Seed rounds (top funding stages).
- Majority of deals are located in United States, France.
- Strong thematic focus on Health Care, Therapeutics, Biotechnology.
- Led 1 rounds in the past year.
Stage Focus
- Series A (33%)
- Series B (33%)
- Seed (17%)
- Series Unknown (8%)
- Grant (8%)
Country Focus
- United States (92%)
- France (8%)
Industry Focus
- Health Care
- Therapeutics
- Biotechnology
- Pharmaceutical
- Life Science
- Genetics
- Biopharma
- Health Diagnostics
- Wellness
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
